Variant report
Variant | esv3407930 |
---|---|
Chromosome Location | chr3:54749512-54753810 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs569128674 | chr3:54749533-54749534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs537911759 | chr3:54749536-54749537 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs377523742 | chr3:54749537-54749538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs138250975 | chr3:54749553-54749554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs551467390 | chr3:54749575-54749576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs149219868 | chr3:54749611-54749612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs541089749 | chr3:54749637-54749638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs533647210 | chr3:54749685-54749686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs534198245 | chr3:54749784-54749785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs559402473 | chr3:54749839-54749840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs76030460 | chr3:54749849-54749850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs535413804 | chr3:54749878-54749879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs555573707 | chr3:54749889-54749890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs577844383 | chr3:54749931-54749932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs181891759 | chr3:54749967-54749968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs544284488 | chr3:54749982-54749983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs545268208 | chr3:54749992-54749993 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs564049106 | chr3:54750026-54750027 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs564167107 | chr3:54750049-54750050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs147345699 | chr3:54750077-54750078 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs577851670 | chr3:54750079-54750080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs368482222 | chr3:54750081-54750082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs185184889 | chr3:54750090-54750091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs73072204 | chr3:54750107-54750108 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs199672526 | chr3:54750120-54750121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs556009986 | chr3:54750151-54750152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs146901025 | chr3:54750166-54750167 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs139071721 | chr3:54750169-54750170 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs562699556 | chr3:54750209-54750210 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs13084602 | chr3:54750311-54750312 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs142973216 | chr3:54750312-54750313 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs371475254 | chr3:54750360-54750361 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs571400090 | chr3:54750395-54750396 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs634393 | chr3:54750421-54750422 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs538875218 | chr3:54750459-54750460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs547749056 | chr3:54750472-54750473 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs113480527 | chr3:54750481-54750482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs147028258 | chr3:54750487-54750488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs190516586 | chr3:54750513-54750514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs553856851 | chr3:54750517-54750518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs569220782 | chr3:54750609-54750610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs538028863 | chr3:54750611-54750612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs558017034 | chr3:54750614-54750615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs577643731 | chr3:54750635-54750636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs539973583 | chr3:54750682-54750683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs569144116 | chr3:54750692-54750693 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs573561890 | chr3:54750712-54750713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs374690495 | chr3:54750728-54750729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs562841518 | chr3:54750737-54750738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs531924623 | chr3:54750740-54750741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Breast cancer | 21785460 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16608533 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21509527 | CNVD |
Prostate cancer | 18632612 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Breast cancer | 19490591 | CNVD |
Autism | 18414403 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Metastatic melanoma | 17975146 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:54743800-54751400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr3:54745200-54750200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr3:54745200-54751600 | Weak transcription | H1 Cell Line | embryonic stem cell |
4 | chr3:54746800-54751600 | Weak transcription | Right Atrium | heart |
5 | chr3:54750200-54750400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr3:54751200-54751600 | Weak transcription | H9 Cell Line | embryonic stem cell |
7 | chr3:54751400-54751600 | Bivalent/Poised TSS | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr3:54751400-54751600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr3:54751400-54751600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr3:54751400-54752000 | Genic enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
11 | chr3:54751600-54751800 | ZNF genes & repeats | H1 Cell Line | embryonic stem cell |
12 | chr3:54751600-54751800 | ZNF genes & repeats | Esophagus | oesophagus |
13 | chr3:54751600-54751800 | Enhancers | Right Atrium | heart |
14 | chr3:54751600-54751800 | Enhancers | Skeletal Muscle Female | skeletal muscle |
15 | chr3:54751600-54752000 | Flanking Bivalent TSS/Enh | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
16 | chr3:54751600-54752000 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |
17 | chr3:54751600-54752000 | Flanking Active TSS | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
18 | chr3:54751600-54752000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
19 | chr3:54751600-54752000 | Bivalent/Poised TSS | Fetal Lung | lung |
20 | chr3:54752000-54752200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
21 | chr3:54752000-54752800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |